Work

Potential use of homologous recombination deficiency score as an indicator of therapy selection in leiomyosarcoma patients.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e23539

Authors: Yuhong Zhou, Xi Guo, He Guo, Rongyuan Zhuang, Wenshuai Liu, Yong Zhang, Hanxing Tong, Zhiming Wang, Yan Wang, Chentao Lv, Weiqi Lu, Chun Dai, Jun Liu

Institutions: Fudan University, Zhongshan Hospital, GenomiCare (China), Shanghai Public Health Clinical Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3029458920

Cites:

Cited by:

Related to: 10